ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 147 filers reported holding ATARA BIOTHERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $72 | -10.0% | 24,844 | +1.7% | 0.00% | -100.0% |
| Q4 2022 | $80 | -99.9% | 24,422 | -5.5% | 0.00% | 0.0% |
| Q3 2022 | $98,000 | +4.3% | 25,843 | +113.7% | 0.00% | 0.0% |
| Q2 2022 | $94,000 | -34.7% | 12,095 | -21.7% | 0.00% | 0.0% |
| Q1 2022 | $144,000 | -33.3% | 15,447 | +12.6% | 0.00% | 0.0% |
| Q4 2021 | $216,000 | +5.4% | 13,719 | +19.8% | 0.00% | 0.0% |
| Q3 2021 | $205,000 | -8.9% | 11,451 | +87.4% | 0.00% | 0.0% |
| Q2 2018 | $225,000 | -13.5% | 6,110 | -8.4% | 0.00% | -50.0% |
| Q1 2018 | $260,000 | +381.5% | 6,668 | +178.9% | 0.00% | – |
| Q2 2016 | $54,000 | +35.0% | 2,391 | +14.3% | 0.00% | – |
| Q1 2016 | $40,000 | -4.8% | 2,092 | +32.1% | 0.00% | – |
| Q4 2015 | $42,000 | -35.4% | 1,584 | -22.9% | 0.00% | -100.0% |
| Q3 2015 | $65,000 | +160.0% | 2,055 | +337.2% | 0.00% | – |
| Q2 2015 | $25,000 | – | 470 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Antipodean Advisors LLC | 1,000,000 | $1,610,000 | 11.42% |
| Redmile Group, LLC | 6,048,123 | $9,737,478 | 0.37% |
| Baupost Group | 9,773,616 | $15,736 | 0.28% |
| JOSH ARNOLD INVESTMENT CONSULTANT, LLC | 170,000 | $273,700 | 0.27% |
| MAVERICK CAPITAL LTD | 6,290,713 | $10,128,048 | 0.22% |
| 683 Capital Management, LLC | 1,000,000 | $1,610,000 | 0.12% |
| WASATCH ADVISORS LP | 8,283,981 | $13,337,209 | 0.08% |
| PACIFIC HEIGHTS ASSET MANAGEMENT LLC | 525,000 | $845,250 | 0.08% |
| STALEY CAPITAL ADVISERS INC | 750,000 | $1,207,500 | 0.06% |
| XTX Topco Ltd | 136,841 | $220,314 | 0.04% |